Bulgaria pharmaceutical products over time
US$, annual.
In more detail
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$1.2 billion | 90.2% |
| 3002 Human blood | US$63.7 million | 4.7% |
| 3003 Medicaments | US$40.6 million | 3.0% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$11.9 million | 0.9% |
| 3006 Pharmaceutical goods | US$11.4 million | 0.8% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$5.7 million | 0.4% |
| Product | Value | Share |
|---|---|---|
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$946.5 million | 69.8% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$155.0 million | 11.4% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$48.0 million | 3.5% |
| 300440 Medicaments: containing alkaloids or their derivatives (but not hormones or antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$38.8 million | 2.9% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$36.8 million | 2.7% |
| 300339 Medicaments: containing hormones (excluding insulin), (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale | US$18.5 million | 1.4% |
| 300220 Vaccines: for human medicine | US$14.9 million | 1.1% |
| 300432 Medicaments: containing adrenal cortex hormones (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$14.9 million | 1.1% |
| 300390 Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | US$11.5 million | 0.8% |
| 300210 Blood: human and animal, antisera and other blood fractions | US$11.1 million | 0.8% |
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$1.7 billion | 76.0% |
| 3002 Human blood | US$412.2 million | 18.7% |
| 3003 Medicaments | US$61.8 million | 2.8% |
| 3006 Pharmaceutical goods | US$26.0 million | 1.2% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$24.0 million | 1.1% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$4.7 million | 0.2% |
| Product | Value | Share |
|---|---|---|
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$1.4 billion | 64.6% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$342.8 million | 15.6% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$65.3 million | 3.0% |
| 300390 Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | US$46.7 million | 2.1% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$42.1 million | 1.9% |
| 300432 Medicaments: containing adrenal cortex hormones (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$37.9 million | 1.7% |
| 300431 Medicaments: containing insulin (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$36.9 million | 1.7% |
| 300450 Medicaments: containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale | US$35.6 million | 1.6% |
| 300220 Vaccines: for human medicine | US$34.7 million | 1.6% |
| 300440 Medicaments: containing alkaloids or their derivatives (but not hormones or antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$22.1 million | 1.0% |
Shares are of Bulgaria's pharmaceutical products in the same direction. See Pharmaceutical products for all countries or all of Bulgaria's trade.
More Bulgaria products
- 27 Mineral fuels, mineral oils and products of their distillation
- 85 Electrical machinery and equipment and parts thereof
- 84 Machinery and mechanical appliances, boilers, nuclear reactors
- 74 Copper and articles thereof
- 87 Vehicles
- 26 Ores, slag and ash
- 93 Arms and ammunition
- 39 Plastics and articles thereof
- 10 Cereals
- 72 Iron and steel
- 90 Optical, photographic, cinematographic, measuring, checking, medical or surgical instruments and apparatus
- 73 Iron or steel articles
Bulgaria pharmaceutical products: questions and answers
How much pharmaceutical products does Bulgaria export?
In 2024, Bulgaria exported US$1.4 billion of pharmaceutical products (HS chapter 30), 2.7% of its total exports. That ranks it 33 of 213 exporting countries in the data.
What are Bulgaria's biggest pharmaceutical products exports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$1.2 billion), Human blood (3002, US$63.7 million), Medicaments (3003, US$40.6 million).
How much pharmaceutical products does Bulgaria import?
In 2024, Bulgaria imported US$2.2 billion of pharmaceutical products (HS chapter 30), 4.2% of its total imports. That ranks it 50 of 226 importing countries in the data.
What are Bulgaria's biggest pharmaceutical products imports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$1.7 billion), Human blood (3002, US$412.2 million), Medicaments (3003, US$61.8 million).
